DESCRIPTION: This is a collaborative group investigation to study the
potential risks or preventive properties of exogenous hormones and
prophylactic surgery for breast and ovarian cancer development in BRCA1 and
BRCA2 carriers. The goals of this study are to: 1) identify families with
BRCA1 and BRCA2 mutations; 2) establish whether oral contraceptive use
protects against ovarian cancers in carriers of BRCA1 mutations; 3)
establish whether tubal ligation protects against ovarian cancer in carriers
of BRCA1 and BRCA2 mutations; 4) establish whether oral contraceptive use
increases the risk of breast cancer in BRCA1 and BRCA2 mutation carriers; 5)
establish whether hormone replacement therapy increases the risk of breast
cancer in carriers of BRCA1 and BRCA2 mutations; 6) establish if
oophorectomy is associated with a reduction in mortality from ovarian cancer
in comparison to observational therapy; 7) establish if an oophorectomy
reduces the risk of breast cancer; and 8) establish if a prophylactic
mastectomy reduces the mortality from breast cancer in comparison to
mammographic screening.
Error Notice
The database may currently be offline for maintenance and should be operational soon. If not, we have been notified of this error and will be reviewing it shortly.
We apologize for the inconvenience.
- The DCCPS Team.